We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

Doctors report rising hip replacements among young Indians post-COVID, linking steroid use and avascular necrosis to severe ...

FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription ...

CHICAGO (WLS) -- As the COVID-19 pandemic spreads, hospitals around the world have begun testing convalescent plasma as a potential treatment. The University of Chicago Medicine is one facility who is ...

Ebola spreads through bodily fluids and has a higher fatality rate, while COVID-19 spreads through the air and infects far ...

There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nirmatrelvir/ritonavir and molnupiravir may be used for ...

“Got milk? Cure COVID” was a meme that started circulating after one of our discoveries from the University of Florida went public. It playfully highlighted a major medical milestone: We had found a ...

FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica ...